No Data
No Data
Simulations Plus to Participate in 21st Annual Craig-Hallum Institutional Investor Conference
Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus"), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced that
Craig-Hallum Reaffirms Their Buy Rating on Simulations Plus (SLP)
Director Daniel Weiner Sells 3,000 Shares of Simulations Plus Inc (SLP)
Simulations Plus(SLP.US) Director Sells US$25,000 in Common Stock
$Simulations Plus(SLP.US)$ Director LaVange Lisa sold 500 shares of common stock on May 14, 2024 at an average price of $50 for a total value of $25,000.Source: Announcement What is statement of chang
Simulations Plus(SLP.US) Director Sells US$150.39K in Common Stock
$Simulations Plus(SLP.US)$ Director WEINER DANIEL L sold 3,000 shares of common stock on May 14, 2024 at an average price of $50.13 for a total value of $150.39K.Source: Announcement What is statement
Simulations Plus Releases GastroPlus X, The Next Generation PBPK/PBBM Modeling & Simulation Software
Redesigned platform offers ease-of-use, enhanced software engineering, and significant productivity gains for users Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of modeling and simulation solutions for the